carbon tetrachloride has been researched along with imatinib mesylate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, T; Asada, K; Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Namisaki, T; Noguchi, R; Tsujimoto, T; Uemura, M; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Chen, MF; Chen, TC; Kuo, WL; Lee, JF; Tsai, CN; Yu, MC | 1 |
| Bugyik, E; Dezső, K; Mózes, M; Nagy, P; Paku, S; Rókusz, A; Szücs, A; Veres, D | 1 |
| El-Hadidy, WF; El-Khatib, AS; El-Mezayen, NS; El-Refaie, WM; Khattab, MM; Shalaby, TI | 1 |
| Aghdaei, HA; Asadirad, A; Baghaei, K; Ghavami, S; Gitiara, A; Hashemi, SM; Hatami, B; Joharchi, K; Mazhari, S; Rad, RE; Tokhanbigli, S; Zali, MR; Łos, MJ | 1 |
| Aghdaei, HA; Alavifard, H; Baghaei, K; Ghavami, S; Hatami, B; Mazhari, S; Meyfour, A; Tokhanbigli, S; Zali, MR | 1 |
6 other study(ies) available for carbon tetrachloride and imatinib mesylate
| Article | Year |
|---|---|
Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzamides; Carbon Tetrachloride; Drug Synergism; Drug Therapy, Combination; Imatinib Mesylate; Immunohistochemistry; Liver; Liver Cirrhosis, Experimental; Male; Muscle, Smooth; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Inbred F344; Receptors, Platelet-Derived Growth Factor; Severity of Illness Index; Transforming Growth Factor beta | 2006 |
Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.
Topics: Animals; Apoptosis; Benzamides; Blotting, Western; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Flow Cytometry; Hepatic Stellate Cells; Imatinib Mesylate; Liver Cirrhosis, Experimental; Liver Regeneration; Male; Mice; Mice, Inbred C3H; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Real-Time Polymerase Chain Reaction | 2012 |
Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Disease Models, Animal; Erlotinib Hydrochloride; Fibrosis; Imatinib Mesylate; Keratin-19; Liver; Liver Cirrhosis; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Protein Kinase Inhibitors; Thioacetamide; Transforming Growth Factor beta | 2017 |
Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Drug Liberation; Hepatic Stellate Cells; Imatinib Mesylate; Liposomes; Liver; Liver Cirrhosis; Male; Nanomedicine; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Treatment Outcome | 2017 |
Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
Topics: Animals; Bone Marrow; Carbon Tetrachloride; Combined Modality Therapy; Disease Models, Animal; Imatinib Mesylate; Liver; Liver Cirrhosis; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor | 2020 |
Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124.
Topics: Animals; Carbon Tetrachloride; Hepatic Stellate Cells; Imatinib Mesylate; Interleukin-6; Liver Cirrhosis; MicroRNAs; Rats; Rats, Sprague-Dawley | 2023 |